Company Name, Ticker, Industry, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
GNBT's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Generex Biotechnology Corp News
Generex Biotechnology Corp's Revenue per Employee
Generex Biotechnology Corp's Dividend Pay out
Generex Biotechnology Corp Business Description
Generex Biotechnology Corp Executive Officers
Economic Indicators
Fundamentals
Generex Biotechnology Corp Growth Rates
Generex Biotechnology Corp Profitability
Generex Biotechnology Corp Valuation
Generex Biotechnology Corp Management Effectiveness
Generex Biotechnology Corp Financial Strength
Generex Biotechnology Corp Efficiency
Generex Biotechnology Corp Dividend
Financials
Generex Biotechnology Corp Business Segments
Generex Biotechnology Corp Income Statement
Generex Biotechnology Corp Balance Sheets
Generex Biotechnology Corp Cash Flow Statement
Generex Biotechnology Corp Geographic Information
Suppliers
Generex Biotechnology Corp Suppliers Performance
GNBT Suppliers Stock Performance
GNBT Suppliers Growth Rates
GNBT Suppliers Data
GNBT Suppliers Efficiency
GNBT Suppliers Management Effectiveness
GNBT Suppliers Valuation
GNBT Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Generex Biotechnology Corp Market Share
Generex Biotechnology Corp Competition Performance
Generex Biotechnology Corp Competitors Results
GNBT Competitors Stock Performance
GNBT Competitors Growth Rates
GNBT Workforce Efficiency at the Competitors
GNBT Competitors Efficiency
GNBT Competitors Management Effectiveness
GNBT Competitors Valuation
Customers & Markets
Generex Biotechnology Corp Customers Demand
GNBT Customers Expenditure Growth Rates
GNBT Customers Performance
GNBT Customers Stock Performance
GNBT Customers Growth Rates
GNBT Workforce Efficiency at the Customers
GNBT Customers Efficiency
GNBT Customers Management Effectiveness
GNBT Customers Valuation
GNBT Customers by Companys' Segments
Charts & Quotes
Generex Biotechnology Corp Comparison Charts
GNBT OHLC Charts
GNBT's Tehnical Upper Indicators
GNBT's Tehnical Lower Indicators
GNBT's Weekly Charts
GNBT's Monthly Charts
Generex Biotechnology Corp's Profile
Company Charts and Quotes
Generex Biotechnology Corp News
Generex Biotechnology Corp's Business Segments
Generex Biotechnology Corp's Income Statement
Generex Biotechnology Corp's Balance Sheets
Generex Biotechnology Corp's Cash Flow Statement
Generex Biotechnology Corp's Profitability
Generex Biotechnology Corp's Financials
Generex Biotechnology Corp's Free Cash Flow Margin
Generex Biotechnology Corp's Suppliers
Generex Biotechnology Corp's Competitors
Generex Biotechnology Corp's Markets & Customers
Generex Biotechnology Corp's Market Share
GNBT's Suppliers Efficiency
GNBT's Competitors Valuation
GNBT's Charts Chaikin Oscillator
Generex Biotechnology Corp's Customers Growth Rates
Economic Indicators
Revenue Growth by Industry
Stock Performance Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Consumer Price Index CPI
News
Economy News
Stock News
Financial Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• F. Cash Flow Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Generex Biotechnology Corp
(
GNBT
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Generex Biotechnology's Yearly Free Cash Flow Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
GNBT Annual Free Cash Flow Growth
2020
2019
2018
2017
2016
Y / Y Annual Free Cash Flow Change
-
-
-
-
-
Annual Free Cash Flow (in millions $)
$-6.13
$-9.89
$-2.29
$-1.17
$0.00
GNBT Company Profile
>>
Back to GNBT Fundamentals at a Glance
>>
Back to GNBT Growth Comparisons
Annual Free Cash Flow Growth Comment
Generex Biotechnology Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2020 Annual Free Cash Flow within Healthcare Sector
Y/Y Free Cash Flow Growth %
2020 Annual Free Cash Flow
Ligand Pharmaceuticals Incorporated
-93.58 %
$ 50.128 millions
Conmed Corporation
-27.07 %
$ 54.745 millions
Eagle Pharmaceuticals inc
-43.40 %
$ 31.250 millions
Xencor Inc